The missing species in a weight-loss headline

Original captioned explainer · 48 seconds · No audio

Transcript

0 seconds — The missing species
In a weight-loss headline. Before applying a headline to your pet, check what the original study actually asked.

8 seconds — 01 / Exact compound
Semaglutide is not exenatide. A drug class is a starting category. Different compounds are not interchangeable evidence.

16 seconds — 02 / Species and population
Dogs? Cats? People?. Healthy laboratory animals and client-owned patients can answer different research questions.

24 seconds — 03 / Formulation and route
Tablet. Injection. Implant.. The dog paper studied oral semaglutide with an absorption enhancer. The cat paper studied an exenatide implant.

32 seconds — 04 / Study endpoint
Absorption is not treatment benefit. Measuring how a compound enters the body does not establish weight or diabetes outcomes in pet patients.

40 seconds — Bring a clearer question
PetPeptideGuide.com. Read the semaglutide evidence guide. Then use the free veterinary-visit checklist. Sources accompany the video.

Sources and context

Buckley et al.: oral semaglutide absorption; Klotsman et al.: exenatide implant in cats. These studies address different compounds and research questions. See the linked article for the complete evidence comparison.